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Glomerular filtration: the charge 
debate charges ahead
Jeffrey H. Miner1
The concept that the glomerular filtration barrier exhibits charge 
selectivity is a basic tenet of renal physiology. Heparan sulfate is a major 
contributor of glomerular anionic charge. In a new study, prevention 
of podocytes from synthesizing heparan sulfate, via mutation of 
Ext1, causes only mild, statistically insignificant albuminuria, despite 
dramatic alterations in glomerular anionic charge.
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The glomerular filtration barrier 
(Figure 1) has been the subject of intense 
study for decades. As the physical separa-
tion between the vasculature and the uri-
nary space, it consists of two cell types: 
the glomerular endothelial cell, which 
is fenestrated, and the podocyte, which 
extends foot processes that interdigitate 
with those of adjacent podocytes to cover 
the outer aspect of glomerular capillar-
ies. Juxtaposed foot processes are linked 
to each other by a specialized intercel-
lular junction, the glomerular slit dia-
phragm, which both creates a passage for 
filtrate and serves as the final structure 
that plasma proteins must cross before 
reaching the urinary space. Between 
the endothelium and the podocyte is 
a specialized extracellular matrix, the 
glomerular basement membrane (GBM). 
Defects in any one component of this 
three-layered barrier can cause proteinu-
ria, suggesting that they each contribute 
to the glomerular filter. However, despite 
extraordinary progress in this field over 
the past 10 years, the mechanisms of bar-
rier function and malfunction remain 
highly controversial.1–3
That the glomerular filtration barrier 
includes a charge-selective component, in 
addition to a size-selective one, has been a 
cornerstone of renal physiology for dec-
ades.4 The concept of charge selectivity 
emerged from the use of tracers of similar 
composition and size but with different 
degrees of positive or negative charge; the 
less negative or more positive the charge, 
the greater the penetration into or across 
the filtration barrier (Figure 1). Further-
more, biochemical and morphological 
studies showed that the GBM harbors 
heparan sulfate proteoglycans (HSPGs) 
whose highly sulfated glycosaminoglycan 
side chains would be expected to impart 
negative charge that could contribute to, if 
not serve as, the charge-selective barrier. 
A detailed discussion of heparan sulfate’s 
contribution to anionic-charge density 
appeared very recently in this journal.5 
Infusion of kidneys with heparinase, fol-
lowed by incubation with the enzyme, 
removed negative charge from within the 
GBM and at the same time disrupted the 
barrier to native ferritin.4
From a translational research stand-
point, the concept of a charge barrier 
is attractive, as multiple studies have 
demonstrated reduced anionic-charge 
density in the setting of diabetes. 
Replacement of this missing charge 
could conceivably reduce albuminuria 
and prevent or slow the onset of the 
associated nephropathy. This hypothe-
sis has been tested in clinical trials with 
sulodexide, a glycosaminoglycan mixture 
of heparan sulfate and dermatan sul-
fate.6 Sulodexide successfully improved 
albuminuria in both type 1 and type 2 
diabetics,6,7 but the mechanisms for this 
reduction and the long-term effects on 
progression of kidney disease remain to 
be determined.
With recent advances in (1) devel-
oping new tracer macromolecules and 
techniques for physiological studies, (2) 
defining the identities and mechanisms 
of synthesis of charged cell-surface and 
GBM proteins that localize to the filtra-
tion barrier, and (3) manipulating the 
mouse genome, there has been a flurry 
of new data regarding the extent to which 
anionic charge influences the effective-
ness of the barrier to plasma proteins. In 
short, most of the results can be viewed as 
unsupportive of the concept that charge 
selectivity is paramount. Our own stud-
ies show that removing agrin, the major 
GBM HSPG,8 also removes much of the 
anionic charge that is detectable in the 
GBM by labeling with polyethyleneimine, 
a cationic probe. There were no appar-
ent changes in albumin permselectivity, 
either under normal circumstances or in 
the setting of overload proteinuria, and 
the rate of clearance of an intravenously 
injected negatively charged tracer did not 
differ from control.9 Our results are in 
agreement with those showing that wide-
spread expression of human heparanase 
in transgenic mice significantly reduces 
anionic charge in the GBM but does not 
lead to ultrastructural or permselectivity 
defects.10 Nevertheless, in both of these 
studies there are likely to be substantial 
amounts of remaining HSPGs associated 
with the filtration barrier that could con-
tribute to a charge barrier.
Chen et al.11 (this issue) investigated 
the role of HSPGs in glomerular filtration. 
Their paper addresses the function of 
heparan sulfate and its associated charge 
via mutation of Ext1, which encodes an 
enzyme subunit required for heparan 
sulfate biosynthesis. Heterozygous null 
mutations in human EXT1 cause multiple 
exostoses type I, a disease characterized 
by benign outgrowths of bones. Here, a 
homozygous knockout of Ext1 specifi-
cally in podocytes did not lead to the 
dramatic defects in glomerular filtration 
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that would be expected if HSPGs con-
tribute significantly to charge selectiv-
ity. In this mouse, neither extracellular 
HSPGs synthesized by podocytes, such as 
agrin, nor podocyte cell-surface HSPGs, 
such as syndecans and perhaps other 
unknown HSPGs, should manifest their 
usual negative-charge densities. This was 
validated in part by observed reductions 
in both total glomerular heparan sulfate 
immunoreactivity and polyethyleneimine 
labeling of the GBM.11 Although there 
was some renal hypertrophy at 8 months 
of age, there was no perinatal death, no 
postnatal lethality, and only mild albu-
minuria that was not statistically differ-
ent from controls. On the other hand, 
ultrastructural analysis did reveal changes 
in podocyte foot process architecture 
and focal thickening of the GBM. Also, 
proximal tubules showed evidence of 
elevated protein resorption activity, sug-
gesting that there may be a more sub-
stantial glomerular leak than indicated 
by the level of albumin reaching the final 
urine. Interestingly, a case of adult-onset 
steroid-sensitive nephrotic syndrome was 
recently reported in an individual carry-
ing an EXT1 mutation,12 but there are no 
other such reports in the literature.
These podocyte Ext1 knockout results, 
together with others discussed above, can 
be interpreted in a number of ways. First, 
that there are defects (though mild) in the 
Ext1 mutant animals suggests that HSPGs 
are important for charge barrier integrity, 
but their reduction might be compen-
sated for in part by unknown changes in 
glomerular-cell gene expression. Alterna-
tively, HSPGs may be important not for 
establishing a charge-selective barrier, but 
rather for aspects of podocyte homeosta-
sis that are unrelated to a charge barrier. 
Perhaps negative charges associated with 
the endothelium, the GBM, or podocyte 
foot processes that do not rely on heparan 
sulfate are the major contributors to 
charge selectivity. One such possibility is 
the sialo- and sulfoprotein podocalyxin, 
present on the surfaces of both podocytes 
and endothelial cells.4 Podocalyxin’s high 
sialic acid and sulfate content imparts it 
with significant negative charge.13 Muta-
tion of GNE/MNK, an enzyme required 
for sialic acid biosynthesis, results in 
severe podocyte defects, GBM splitting, 
and proteinuria that are associated with 
hyposialylation of podocalyxin.14 How-
ever, despite the clear importance of its 
negative charge for glomerular filtration, 
podocalyxin may be more important 
for establishing and maintaining podo-
cyte foot process architecture and spac-
ing than for contributing to glomerular 
charge selectivity.
The recent in vivo approaches to charge 
barrier analysis discussed here have 
attempted to test the hypothesis that (to 
paraphrase a famous line from a 1989 
baseball film) ‘If you disrupt it, it will leak.’ 
However, the podocalyxin example above 
is demonstrative of the overall challenge 
for understanding the mechanisms of 
glomerular filtration: for a lesion caus-
ing an alteration in glomerular charge, 
it may be difficult to determine whether 
any observed proteinuria is due to loss 
of charge selectivity per se, or to a direct 
impact on either GBM organization or 
glomerular-cell health. Nevertheless, 
investigators will certainly continue to 
attack the integrity of the charge barrier 
and, by doing so, could raise additional 
questions regarding its existence.1
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When less is more: apoptosis 
during acute kidney injury
Istvan Arany1
The paper by Ma and Devarajan suggests that the subtle apoptotic 
events that occur in the distal nephron after acute kidney injury might 
have a greater than expected impact on the adjacent proximal tubules 
and kidney function. Understanding these events might facilitate 
development of therapeutic means to ameliorate acute kidney injury.
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figure 1 | Interaction between distal tubules and proximal tubules during acute kidney 
injury. The form and extent of cell death provoked by acute kidney injury (AKI) depend on various 
parameters, as listed. Through paracrine regulation, distal tubules might attenuate injury and/or 
augment regeneration of proximal tubules. Accordingly, inhibition of injury of distal tubules might 
positively affect survival of proximal tubules as well.
In this issue of Kidney International, Ma 
and Devarajan1 report that Daxx protein 
expression increases in the distal nephron 
segments of the kidney during ischemia/
reperfusion injury in cells that express 
markers of apoptosis. The exact role of the 
death domain-associated protein Daxx is 
unclear, as it may play a role in either cell 
death or survival. Ma and Devarajan1 
present data to suggest that it plays a role 
in the apoptosis of distal tubule cells, as 
inhibition of its expression prevents apop-
tosis in vitro and it is coexpressed with 
markers of apoptosis in vivo. This obser-
vation refocuses attention on the issue of 
the relative importance of distal versus 
proximal cell injury in the pathogenesis 
of acute kidney injury. The issue was first 
raised by observations on the molecular 
responses to injury,2 which showed prom-
inent responses in the distal nephron, and 
later by detailed studies of the nature of 
cell death induced by ischemia/reper-
fusion injury.3 It is generally accepted 
that—especially after ischemic injury—
the proximal tubule (PT) is more sus-
ceptible to damage than the distal tubule 
(DT).4 It has also been established that 
whereas the PT undergoes necrosis, the 
predominant form of cell death in the DT 
is apoptosis.5 In one recent study, inhibit-
ing apoptosis in the distal nephron had 
a significant effect on kidney function.6 
The studies of Ma and Devarajan1 now 
extend these observations and identify a 
possible key regulator of the process. How 
could inhibition of apoptosis, especially in 
the distal nephron, affect renal function 
so profoundly? Perhaps a more detailed 
look at the nature of cell death induced 
by acute kidney injury will suggest some 
possible answers.
Both the S3 segment of the PT, so 
prominently involved in necrotic cell 
death after acute kidney injury, and the 
straight portion of the DT, where apop-
tosis predominates, are located in close 
proximity in the outer medulla of the 
kidney. The environment of this region of 
the kidney is particularly harsh, with low 
oxygen tension and consequent increased 
generation of reactive oxygen species, and 
continued osmotic stress. There are also 
significant differences in metabolic activi-
ties between the PT and DT: the DT has 
